| 1. Impact of Breast Reconstruction on Biophysical Parameters of Mammary Skin in Patients Receiving Postmastectomy Radiotherapy for Breast Cancer |
Page:206—217 |
| 2. Breast Cancer Statistics in Korea, 2018 |
Page:123—137 |
| 3. Comparison between Gasless and Gas-Inflated Robot-Assisted NippleSparing Mastectomy |
Page:183—195 |
| 4. Diffusion-Weighted Magnetic Resonance Imaging for Breast Cancer Screening in High-Risk Women: Design and Imaging Protocol of a Prospective Multicenter Study in Korea |
Page:218—228 |
| 5. Comparison of Single Incision Endoscopic Nipple-Sparing Mastectomy and Conventional NippleSparing Mastectomy for Breast Cancer Based on Initial Experience |
Page:196—205 |
| 6. Clinical Outcomes Following Letrozole Treatment according to Estrogen Receptor Expression in Postmenopausal Women: LETTER Study (KBCSG-006) |
Page:164—174 |
| 7. Clinical Features of Breast Cancer in South Korean Patients with Germline TP53 Gene Mutations |
Page:175—182 |
| 8. MicroRNA-130a Increases and Predicts Cardiotoxicity during Adjuvant Chemotherapy in Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer |
Page:153—163 |
| 9. Breast-Conserving Surgery after Neoadjuvant Chemotherapy Using a Three-Dimensional-Printed Surgical Guide Based on Supine Magnetic Resonance Imaging: A Case Report |
Page:235—240 |
| 10. Osseous Metaplasia in Hemangiomas of the Breast: Case Reports and Literature Review |
Page:229—234 |
| 11. Increased Melanoma-Associated Antigen C2 Expression Affords Resistance to Apoptotic Deathin Suspension-Cultured Tumor Cells |
Page:138—152 |
| 12. Intraductal Migration of a Breast Tissue Marker Placed under Ultrasound Guidance during COVIDInduced Delay of Surgery |
Page:402—408 |
| 13. AC092127.1-miR-451a-AE binding protein 2 Signaling Facilitates Malignant Properties of Breast Cancer |
Page:389—401 |
| 14. Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab |
Page:359—366 |
| 15. Magnetic Resonance Imaging-Guided Breast Biopsy in Korea: A 10-Year Follow-Up Experience |
Page:377—388 |
| 16. Effect of Poloxamer-Based ThermoSensitive Sol-Gel Agent on Upper Limb Dysfunction after Axillary Lymph Node Dissection: A Double-Blind Randomized Clinical Trial |
Page:367—376 |
| 17. Pyoderma Gangrenosum Mimicking Wound Infection after Breast Cancer Surgery |
Page:409—416 |
| 18. Paraneoplastic Encephalitis Associated with Locally Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer |
Page:106—116 |
| 19. Palbociclib Plus Fulvestrant in Korean Patients from PALOMA-3 With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer |
Page:97—105 |
| 20. Clinical Significance of ReceptorInteracting Protein 3 and Parkin, Essential Molecules for Necroptosis, in Breast Cancer |
Page:34—48 |
| 21. Aesthetic Scar-Less Mastectomy and Breast Reconstruction |
Page:22—23 |
| 22. Association between Number of Retrieved Sentinel Lymph Nodes and Breast Cancer-related Lymphedema |
Page:63—74 |
| 23. Trends in Axillary Surgery for Treating Ductal Carcinoma In Situ: A Korean Population-based Study |
Page:49—62 |
| 24. Standardized Pathology Report for Breast Cancer |
Page:1—21 |
| 25. Relation Between Tumor Size and Lymph Node Metastasis According to Subtypes of Breast Cancer |
Page:75—84 |
| 26. Physicians' Awareness of the Breast Cancer Survivors' Unmet Needs in Korea |
Page:85—96 |
| 27. Ribociclib-Induced Erythema Dyschromicum Perstans (Ashy Dermatosis)–Like Pigmentation in a Metastatic Breast Cancer Patient |
Page:117—121 |
| 28. Long Non-Coding RNA NORAD Inhibits Breast Cancer Cell Proliferation and Metastasis by Regulating miR-155-5p/ SOCS1 Axis |
Page:330—343 |
| 29. Impact of Trastuzumab on Ipsilateral Breast Tumor Recurrence for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer after BreastConserving Surgery |
Page:301—314 |
| 30. The Role of STAT1 in T Helper Cell Differentiation during Breast Cancer Progression |
Page:253—265 |
| 31. In regard to “The Italian Association of Radiotherapy and Oncology Recommendation for Breast Tumor Recurrence: Grades of Recommendation, Assessment, Development and Evaluation Criteria” |
Page:356—357 |
| 32. A Nationwide Study on the Incidence of Breast Cancer in Korean Women with Osteoporosis Receiving Raloxifene Treatment |
Page:280—288 |
| 33. The Italian Association of Radiotherapy and Oncology Recommendation for Breast Tumor Recurrence: Grades of Recommendation, Assessment, Development and Evaluation Criteria |
Page:241—252 |
| 34. Immediate Reconstruction of Large Ptotic Breasts following Vertical Reduction Pattern Nipple-Sparing Mastectomy |
Page:283—300 |
| 35. HOXD Antisense Growth-Associated Long Noncoding RNA Promotes TripleNegative Breast Cancer Progression by Activating Wnt Signaling Pathway |
Page:315—329 |
| 36. Ectopic Male Breast Cancer in Suprapubic Area That Relapsed with Hematogenous Metastasis |
Page:344—348 |
| 37. Usefulness of 3-Dimensional-Printed Breast Surgical Guides for Undetectable Ductal Carcinoma In Situ on Ultrasonography: A Report of 2 Cases |
Page:349—355 |
| 38. Impact of Breast Reconstruction on Biophysical Parameters of Mammary Skin in Patients Receiving Postmastectomy Radiotherapy for Breast Cancer |
Page:206—217 |
| 39. Breast Cancer Statistics in Korea, 2018 |
Page:123—137 |
| 40. Comparison between Gasless and Gas-Inflated Robot-Assisted NippleSparing Mastectomy |
Page:183—195 |
| 41. Diffusion-Weighted Magnetic Resonance Imaging for Breast Cancer Screening in High-Risk Women: Design and Imaging Protocol of a Prospective Multicenter Study in Korea |
Page:218—228 |
| 42. Comparison of Single Incision Endoscopic Nipple-Sparing Mastectomy and Conventional NippleSparing Mastectomy for Breast Cancer Based on Initial Experience |
Page:196—205 |
| 43. Clinical Outcomes Following Letrozole Treatment according to Estrogen Receptor Expression in Postmenopausal Women: LETTER Study (KBCSG-006) |
Page:164—174 |
| 44. Clinical Features of Breast Cancer in South Korean Patients with Germline TP53 Gene Mutations |
Page:175—182 |
| 45. MicroRNA-130a Increases and Predicts Cardiotoxicity during Adjuvant Chemotherapy in Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer |
Page:153—163 |
| 46. Breast-Conserving Surgery after Neoadjuvant Chemotherapy Using a Three-Dimensional-Printed Surgical Guide Based on Supine Magnetic Resonance Imaging: A Case Report |
Page:235—240 |
| 47. Osseous Metaplasia in Hemangiomas of the Breast: Case Reports and Literature Review |
Page:229—234 |
| 48. Increased Melanoma-Associated Antigen C2 Expression Affords Resistance to Apoptotic Deathin Suspension-Cultured Tumor Cells |
Page:138—152 |
| 49. Intraductal Migration of a Breast Tissue Marker Placed under Ultrasound Guidance during COVIDInduced Delay of Surgery |
Page:402—408 |
| 50. AC092127.1-miR-451a-AE binding protein 2 Signaling Facilitates Malignant Properties of Breast Cancer |
Page:389—401 |
| 51. Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab |
Page:359—366 |
| 52. Magnetic Resonance Imaging-Guided Breast Biopsy in Korea: A 10-Year Follow-Up Experience |
Page:377—388 |
| 53. Effect of Poloxamer-Based ThermoSensitive Sol-Gel Agent on Upper Limb Dysfunction after Axillary Lymph Node Dissection: A Double-Blind Randomized Clinical Trial |
Page:367—376 |
| 54. Pyoderma Gangrenosum Mimicking Wound Infection after Breast Cancer Surgery |
Page:409—416 |
| 55. Paraneoplastic Encephalitis Associated with Locally Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer |
Page:106—116 |
| 56. Palbociclib Plus Fulvestrant in Korean Patients from PALOMA-3 With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer |
Page:97—105 |
| 57. Clinical Significance of ReceptorInteracting Protein 3 and Parkin, Essential Molecules for Necroptosis, in Breast Cancer |
Page:34—48 |
| 58. Aesthetic Scar-Less Mastectomy and Breast Reconstruction |
Page:22—23 |
| 59. Association between Number of Retrieved Sentinel Lymph Nodes and Breast Cancer-related Lymphedema |
Page:63—74 |
| 60. Trends in Axillary Surgery for Treating Ductal Carcinoma In Situ: A Korean Population-based Study |
Page:49—62 |
| 61. Standardized Pathology Report for Breast Cancer |
Page:1—21 |
| 62. Relation Between Tumor Size and Lymph Node Metastasis According to Subtypes of Breast Cancer |
Page:75—84 |
| 63. Physicians' Awareness of the Breast Cancer Survivors' Unmet Needs in Korea |
Page:85—96 |
| 64. Ribociclib-Induced Erythema Dyschromicum Perstans (Ashy Dermatosis)–Like Pigmentation in a Metastatic Breast Cancer Patient |
Page:117—121 |
| 65. Long Non-Coding RNA NORAD Inhibits Breast Cancer Cell Proliferation and Metastasis by Regulating miR-155-5p/ SOCS1 Axis |
Page:330—343 |
| 66. Impact of Trastuzumab on Ipsilateral Breast Tumor Recurrence for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer after BreastConserving Surgery |
Page:301—314 |
| 67. The Role of STAT1 in T Helper Cell Differentiation during Breast Cancer Progression |
Page:253—265 |
| 68. In regard to “The Italian Association of Radiotherapy and Oncology Recommendation for Breast Tumor Recurrence: Grades of Recommendation, Assessment, Development and Evaluation Criteria” |
Page:356—357 |
| 69. A Nationwide Study on the Incidence of Breast Cancer in Korean Women with Osteoporosis Receiving Raloxifene Treatment |
Page:280—288 |
| 70. The Italian Association of Radiotherapy and Oncology Recommendation for Breast Tumor Recurrence: Grades of Recommendation, Assessment, Development and Evaluation Criteria |
Page:241—252 |
| 71. Immediate Reconstruction of Large Ptotic Breasts following Vertical Reduction Pattern Nipple-Sparing Mastectomy |
Page:283—300 |
| 72. HOXD Antisense Growth-Associated Long Noncoding RNA Promotes TripleNegative Breast Cancer Progression by Activating Wnt Signaling Pathway |
Page:315—329 |
| 73. Ectopic Male Breast Cancer in Suprapubic Area That Relapsed with Hematogenous Metastasis |
Page:344—348 |
| 74. Usefulness of 3-Dimensional-Printed Breast Surgical Guides for Undetectable Ductal Carcinoma In Situ on Ultrasonography: A Report of 2 Cases |
Page:349—355 |
| 75. Impact of the COVID-19 Pandemic on the Diagnosis and Surgery of Breast Cancer: A Multi-Institutional Study |
Page:491—503 |
| 76. Prognostic Factors in Male Breast Cancer: A Retrospective Nationwide Study in South Korea by the Study of SMARTSHIP Group |
Page:561—568 |
| 77. A Randomized Controlled Trial for Doing vs. Omitting Intraoperative Frozen Section Biopsy for Resection Margin Status in Selected Patients Undergoing Breast-Conserving Surgery (OFF-MAP Trial) |
Page:569—577 |
| 78. Comparison of Long-Term Oncological Outcomes in Oncoplastic Breast Surgery and Conventional BreastConserving Surgery for Breast Cancer: A Propensity Score-Matched Analysis |
Page:520—530 |
| 79. Lipids, Anthropometric Measures, Smoking and Physical Activity Mediate the Causal Pathway From Education to Breast Cancer in Women: A Mendelian Randomization Study |
Page:504—519 |
| 80. Sentinel Lymph Node Biopsy in Breast Cancer Patients With Pathological Complete Response in the Axillary Lymph Node After Neoadjuvant Chemotherapy |
Page:531—541 |
| 81. Imaging Protocol and Criteria for Evaluation of Axillary Lymph Nodes in the NAUTILUS Trial |
Page:554—560 |
| 82. Frailty-Independent Undertreatment Negative Impact on Survival in Older Patients With Breast Cancer |
Page:542—553 |
| 83. Successful Pre-Operative Local Control of Skin Invasion of Breast Cancer Using a Combination of Systemic Chemotherapy and Mohs Paste |
Page:481—490 |
| 84. Histological Findings of Mammary Gland Development and Risk of Breast Cancer in BRCA1 Mutant Mouse Models |
Page:455—462 |
| 85. Neutrophil to Lymphocyte Ratio after Treatment Completion as a Potential Predictor of Survival in Patients with Triple-Negative Breast Cancer |
Page:443—454 |
| 86. Long Noncoding-RNA Component of Mitochondrial RNA Processing Endoribonuclease Promotes Carcinogenesis in Triple-Negative Breast Cancer Cells via the Competing Endogenous RNA Mechanism |
Page:428—442 |
| 87. Fatty Liver in Hormone ReceptorPositive Breast Cancer and Its Impact on Patient's Survival |
Page:417—427 |
| 88. Longitudinal Intravital Imaging of Tumor-Infiltrating Lymphocyte Motility in Breast Cancer Models |
Page:463—473 |
| 89. BRCA1 Reversion Mutation Confers Resistance to Olaparib and Camrelizumab in a Patient with Breast Cancer Liver Metastasis |
Page:474—480 |
